Color Doppler Sonography used to treat premature infants with serious illness

TriMed Staff | | Health Imaging | Screening
Color Doppler sonography is now being used to detect necrotizing entercolitis (NEC), an acquired inflammatory gastrointestinal disease in premature infants. Radiologists are using a unique type of ultrasound in detecting this life-threatening problem by measuring blood flow to the intestines of newborns, according to a study in the May issue of the journal Radiology.

This type of treatment was tested from 2000-2002 at the University of Toronto by examining 30 infants suspected or proven to have NEC. The results of examinations using color Doppler sonography (CDS) against those using abdominal x-rays showed that the CDS results were a more sensitive and detailed, according to the study.

Additional benefits of CDS include its ability to show the severity of the NEC giving physicians more treatment options, it is non-invasive, and free of ionizing radiation, the study said.

TriMed Staff

Related Content

AI beats standard regression models at predicting lung cancer risk
AI reduces CT lung cancer screening workload by nearly 80%
Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk

Around the web

Cardiovascular Business
ASE updates recommendations for assessing right heart function in patients with pulmonary hypertension

The new guidelines were designed to ensure sonographers and other members of the heart team have the information they need to screen patients when appropriate and identify early warnings signs of PH. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care.